RE:RE:Next leg of the uptick from recent lowPotato , potato...obviously I know the Q4 / year end update is coming.
interesting . I did say... " year end"
yet you zoom in on my obvious typo just to throw knives.
Regarding " additional trial with Roche" ...
had they not met the criteria in the earlier phase, that trial branch would be done.
That being the " enrolment expansion of Goblet anal cancer cohort"
based on near tripling of objective response rate, compared to check point inhibor mono therapy
including one complete response.
THAT, is yes a new advancement with Roche. Without meeting the requirements, that cohort would be shut down.
The news in- of- itself is great & should be viewd as such. Wordsmithing & taking any statement out of context, is quite revealing of your motives.